FDA Clears New Blood Test that Could Speed Alzheimer’s Diagnosis and Treatment

Health & LifestyleNews
137

Listen to article (english)

Translate to Spanish or other 102 languages!

With Alzheimer’s rates climbing and diagnoses often delayed until symptoms progress, a new FDA-cleared blood test could mark a turning point in how the disease is identified and managed. Image for illustration purposes
With Alzheimer’s rates climbing and diagnoses often delayed until symptoms progress, a new FDA-cleared blood test could mark a turning point in how the disease is identified and managed. Image for illustration purposes

Mega Doctor News

- Advertisement -

By George Washington University

Newswise – With Alzheimer’s rates climbing and diagnoses often delayed until symptoms progress, a new FDA-cleared blood test could mark a turning point in how the disease is identified and managed.

This week, the FDA cleared Roche’s Elecsys pTau181 test — only the second blood-based biomarker test approved this year for Alzheimer’s disease. The test, developed with Eli Lilly, gives primary care physicians a faster way to help rule out Alzheimer’s in patients showing signs of cognitive decline, potentially reducing reliance on costly PET scans and getting patients to answers — and treatment — sooner.

- Advertisement -
- Advertisement -

Latest news

- Advertisement -
Previous article
HHSC Encourages Preventive Care During Breast Cancer Awareness Month
Next article
STHS Children’s Partners with Spirit Halloween for Pre-Halloween Party for Patients

More Articles

Join NHPO-RGV for an Unforgettable Valley Networking Night, Sept. 17th

Networking is an essential tool for professional success. It helps build meaningful relationships, fosters mentorship and support, encourages the exchange of ideas and industry insights, and creates opportunities for career and business growth.

Study Links Childhood Chemo to Later-in-Life Health Issues

Chemotherapy, which saves the lives of many children with cancer, causes previously unknown DNA alterations in the liver and leaves genetic footprints in other healthy cells as well. These findings could potentially explain the higher risk of health problems later in life.

The Brain Benefits of Caring for Grandkids

If you enjoy spending time with your grandkids, you may be glad to know it can actually offer some cognitive benefits too.

Tick Bites & Arterial Plaque: The Alpha-Gal Link

Researchers are investigating whether the immune response underlying the condition, alpha-gal syndrome, may contribute to plaque buildup in the arteries.
- Advertisement -